US Patent Issued to Certa Therapeutics on Oct. 6 for "Solid forms, salts and polymorphs of anti-fibrotic compounds" (Australian, New Zealander Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,148, issued on Oct. 6, was assigned to Certa Therapeutics Pty Ltd (Melbourne, Australia).

"Solid forms, salts and polymorphs of anti-fibrotic compounds" was invented by Darren James Kelly (Melbourne, Australia), Gareth Rhys Lewis (Melbourne, Australia) and Lorna Helen Mitchell (Auckland, New Zealand).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to solid forms and salts, crystalline and otherwise, of (E)-2-[[3-(3-methoxy-4-propargyloxy)phenyl)-1-oxo-2-propenyl]amino]benzoic acid and pharmaceutical compositions comprising same. The use of such solid forms, salts, and pharmaceutical compositions, for treating, preventing,...